Genentech

IPO

Pioneering the biotechnology industry to deliver life-changing medicines

Public · San Francisco, United States · Founded 1976 · $492.3M raised

Employees
10001+
Founded
1976
Business Model
B2B
Website
gene.com
Total Funding
$492.3M
Last Round
$492.0M Corporate RoundFeb 1990
Rounds
2
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Genentech, a member of the Roche Group and pioneer of biotechnology, discovers and develops breakthrough medicines for serious diseases including cancer, neurological disorders, and ophthalmological conditions. Founded in 1976 as the world's first biotech company, it has delivered over 30 FDA-approved therapies. The company integrates AI end-to-end across its R&D ecosystem to accelerate drug discovery, clinical trials, and manufacturing.

Summary

Genentech is a Biotech company based in San Francisco, United States, founded in 1976. It has raised $492.3M in total across 2 rounds, most recently a $492.0M Corporate Round in Feb 1990. Investors include Kleiner Perkins, Roche and Hambrecht & Quist.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Corporate RoundCorporate RoundFeb 1990
$492.0M

Sign up to see all 3 events

Funding: Seed through Corporate Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Mirador Therapeutics

Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...

San Diego, United States11–50Biotech, Drug Discovery
Series BTotal funding$650.0MOct 2025
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private EquityTotal funding$647.0MFeb 2026
Neumora TherapeuticsIPO

Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...

Watertown, United States51–200Biotech, Drug Discovery
Series BTotal funding$612.0MOct 2022
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Genentech on Indexed.vc
<a href="https://indexed.vc/companies/genentech"><img src="https://indexed.vc/api/badge/company/genentech" alt="Genentech on Indexed.vc" width="260" height="76" /></a>